Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE)

Experimental Neurology

Volumn 241, Issue 1, 2013, Pages 113-121

  Olechowski, Camille J ^a   Tenorio, Gustavo ^a   Sauve, Yves ^a   Kerr, Bradley J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

EAE; Glutamate transporter; Novel object recognition; Pain

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE TRANSPORTER; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EXCITATORY AMINO ACID TRANSPORTER 2 GENE; FEMALE; GENE EXPRESSION; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; MOUSE; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CEFTRIAXONE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXCITATORY AMINO ACID TRANSPORTER 2; EXPLORATORY BEHAVIOR; FEMALE; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; HYPERALGESIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PAIN MEASUREMENT; PAIN THRESHOLD; PEPTIDE FRAGMENTS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; ROTAROD PERFORMANCE TEST; SPINAL CORD; TIME FACTORS;

EID: 84872702792     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.12.012     Document Type: Article

References (35)

1. Alvarez B.V., Gilmour G.S., Mema S.C., Martin B.T., Shull G.E., Casey J.R., Sauvé Y. Blindness caused by deficiency in AE3 chloride/bicarbonate exchanger. PLoS One 2007, 2(9):e839. (Sep 5).
2. Arima Y., Harada M., Kamimura D., Park J.H., Kawano F., Yull F.E., Kawamoto T., Iwakura Y., Betz U.A., Marquez G., Blackwell T.S., Ohira Y., Hirano T., Murakami M. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012, 148:447-457.
3. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
4. D'Intino G., Paradisi M., Fernandez M., Giuliani A., Aloe L., Giardino L., Calza L. Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3070-3075.
5. Fairless R., Williams S.K., Hoffmann D.B., Stojic A., Hochmeister S., Schmitz F., Storch M.K., Diem R. Preclinical retinal neurodegeneration in a model of multiple sclerosis. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32:5585-5597.
6. He Y., Janssen W.G., Rothstein J.D., Morrison J.H. Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus. J. Comp. Neurol. 2000, 418:255-269.
7. He D., Zhou H., Guo D., Hao Z., Wu B. Pharmacologic treatment for memory disorder in multiple sclerosis. Cochrane database of systematic reviews 2011, CD008876.
8. Jongen P.J., Ter Horst A.T., Brands A.M. Cognitive impairment in multiple sclerosis. Minerva Med. 2012, 103:73-96.
9. Mandolesi G., Grasselli G., Musumeci G., Centonze D. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration. Neurol. Sci. 2010, 31:S255-S259.
10. Melzer N., Meuth S.G., Torres-Salazar D., Bittner S., Zozulya A.L., Weidenfeller C., Kotsiari A., Stangel M., Fahlke C., Wiendl H. A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS One 2008, 3:e3149.
11. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., Bähr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 2001, 21:6214-6220.
12. Mitosek-Szewczyk K., Sulkowski G., Stelmasiak Z., Struzynska L. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 2008, 155:45-52.
13. Musgrave T., Benson C., Wong G., Browne I., Tenorio G., Rauw G., Baker G.B., Kerr B.J. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav. Immun. 2011, 25:1677-1688.
14. Musgrave T., Olechowski C.J., Kerr B.J. Learning new tricks from an old dog: using experimental autoimmune encephalomyelitis to study comorbid symptoms in multiple sclerosis. Pain Manag. 2011, 1:571-576.
15. Okada K., Yamashita U., Tsuji S. Modulation of Na(+)-dependent glutamate transporter of murine astrocytes by inflammatory mediators. J. UOEH 2005, 27:161-170.
16. Olechowski C.J., Truong J.J., Kerr B.J. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009, 141:156-164.
17. Olechowski C.J., Parmar A., Miller B., Stephan J., Tenorio G., Tran K., Leighton J., Kerr B.J. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 2010, 149:565-572.
18. Osterberg A., Boivie J., Thuomas K.A. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur. J. Pain 2005, 9:531-542.
19. Owens T., Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 1995, 13:51-73.
20. Pampliega O., Domercq M., Villoslada P., Sepulcre J., Rodriguez-Antiguedad A., Matute C. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J. Neuroimmunol. 2008, 195:194-198.
21. Pollak Y., Orion E., Goshen I., Ovadia H., Yirmiya R. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain Behav. Immun. 2002, 16:533-543.
22. Pollak Y., Ovadia H., Orion E., Weidenfeld J., Yirmiya R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J. Neuroimmunol. 2003, 137:94-99.
23. Quinn T.A., Dutt M., Shindler K.S. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front. Neurol. 2011, 2:50.
24. Ramos K.M., Lewis M.T., Morgan K.N., Crysdale N.Y., Kroll J.L., Taylor F.R., Harrison J.A., Sloane E.M., Maier S.F., Watkins L.R. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 2010, 169:1888-1900.
25. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
26. Sauve Y., Gaillard F. Regeneration in the visual system of adult mammals. Webvision: The Organization of the Retina and Visual System, Salt Lake City (UT) 1995, H. Kolb, E. Fernandez, R. Nelson (Eds.).
27. Sulkowski G., Dabrowska-Bouta B., Kwiatkowska-Patzer B., Struzynska L. Alterations in glutamate transport and group I metabotropic glutamate receptors in the rat brain during acute phase of experimental autoimmune encephalomyelitis. Folia Neuropathol. 2009, 47:329-337.
28. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci. 2003, 23:2899-2910.
29. Svendsen K.B., Jensen T.S., Overvad K., Hansen H.J., Koch-Henriksen N., Bach F.W. Pain in patients with multiple sclerosis: a population-based study. Arch. Neurol. 2003, 60:1089-1094.
30. Svendsen K.B., Jensen T.S., Hansen H.J., Bach F.W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005, 114:473-481.
31. Tao Y.X., Gu J., Stephens R.L. Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Mol. Pain 2005, 1:30.
32. Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G.L., Mutani R., Giordana M.T., Cavalla P. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropathol. Exp. Neurol. 2007, 66:732-739.
33. Wang T., Nagai H., Bouda K., Matsuura S., Takaoka Y., Niwa S., Homma T., Tanaka H., Shudo K. Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats. Acta Pharmacol. Sin. 2000, 21:967-976.
34. Ziehn M.O., Avedisian A.A., Tiwari-Woodruff S., Voskuhl R.R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab. Invest. 2010, 90:774-786.
35. Zou X., Lin Q., Willis W.D. Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats. J. Neurosci. Off. J. Soc. Neurosci. 2000, 20:6989-6997.